Breast-Conserving Therapy for Multiple Ipsilateral Breast Cancer After Neoadjuvant Systemic Therapy
In this retrospective analysis of women with MIBC who underwent BCS after NST, local recurrence (LR) was 1.4% at 3-year median follow-up, which was similar to patients with unifocal breast cancer. These findings suggest BCS is a safe surgical option in well-selected patients with MIBC undergoing NST.
Authors
- Jennifer R. Bellon (ORCID: https://orcid.org/0000-0001-6241-0230)
- Elizabeth A. Mittendorf (ORCID: https://orcid.org/0000-0002-9762-8536)
- T King
- José Pablo Leone (ORCID: https://orcid.org/0000-0002-8537-652X)
- Olga Kantor
- Monika K. Masanam
Institutions
- Brigham and Women's Hospital (US)
- Beth Israel Deaconess Medical Center (US)
- Harvard University (US)
- Emory University (US)
- Northwestern University (PH)
- Dana-Farber Cancer Institute (US)
- Northwestern Medicine (US)
- Dana-Farber Brigham Cancer Center (US)
Publication Details
- Journal
- Annals of Surgical Oncology
- Published
- 2026-01-03
- DOI
- https://doi.org/10.1245/s10434-025-18939-6
- Citations
- 1
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 24.82